Home4016 • TADAWUL
add
Middle East Pharmaceutical Inds Co SJSC
Previous close
SAR 137.00
Day range
SAR 135.60 - SAR 137.90
Year range
SAR 108.00 - SAR 140.60
Market cap
2.72B SAR
Avg Volume
28.84K
P/E ratio
29.24
Dividend yield
1.73%
Primary exchange
TADAWUL
Market news
Financials
Income Statement
Revenue
Net income
| (SAR) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 117.66M | 16.34% |
Operating expense | 45.56M | 17.77% |
Net income | 24.81M | 13.78% |
Net profit margin | 21.09 | -2.18% |
Earnings per share | — | — |
EBITDA | 30.78M | 6.14% |
Effective tax rate | 8.29% | — |
Balance Sheet
Total assets
Total liabilities
| (SAR) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 24.27M | 12.19% |
Total assets | 561.11M | 20.42% |
Total liabilities | 175.94M | 36.59% |
Total equity | 385.17M | — |
Shares outstanding | 20.00M | — |
Price to book | 7.11 | — |
Return on assets | 12.52% | — |
Return on capital | 15.50% | — |
Cash Flow
Net change in cash
| (SAR) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 24.81M | 13.78% |
Cash from operations | 30.01M | 176.13% |
Cash from investing | -12.27M | -209.26% |
Cash from financing | -27.35M | -38.09% |
Net change in cash | -9.60M | 25.59% |
Free cash flow | 8.32M | 1,191.82% |
About
Founded
1998
Headquarters
Website
Employees
632
